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Introduction
In the process of breast cancer development and pro-
gression deregulated expression of growth factors,
their receptors as well as apoptosis' disturbances play
important role [17,19]. The main group of genes influ-
encing apoptosis is the Bcl-2 family with inhibitors
(Bcl-2, Bcl-xL, Mcl-1) and promotors (Bax, Bak, Bad,
Bcl-xS) of this process [26]. Pro- and anti-apoptotic
proteins may form homo- or heterodimers and and
ratio between these proteins influence cell cycle and
apoptosis. Accumulated Bax and Bak proteins could
increase mitochondrial permeability, release
cytochrome C and finally activate the downstream cas-
pase cascade [26]. Anti-apoptotic proteins preserve
mitochondrial structure and function.
Leptin is a hormone produced mainly by the adi-
pose tissue and plays roles in body weight homeosta-
sis, neuroendocrine function, fertility, immune func-
tion and angiogenesis [1]. Leptin effects of action are
thought largely mediated via hypothalamus, but in
recent years it was widely discussed leptin action in
peripheral tissues [32]. In the breast, leptin is required
for normal mammary gland development and lactation
[22]. Recent data revealed that leptin might be
involved in breast cancer development and progres-
sion [30]. Breast cancer cells in culture express differ-
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ent isoforms of the leptin receptor, including the long
signaling form [8, 21]. We previously showed that lep-
tin and its receptor are overexpressed in primary breast
cancer and lymph node metastasis compared with non-
cancerous tissues, possibly due to hypoxia and/or
overexposure of cells to insulin, IGF-I and/or estradiol
[7]. Leptin can stimulate cell growth, regulate apopto-
sis, induce migration and expression of matrix degrad-
ing enzymes and angiogenic factors (such as VEGF)
[9]. It indicates that leptin system might be involved in
the development and progression of neoplasms. Stim-
ulation of the leptin receptor has been reported to acti-
vate multiple signalling pathways such as
JAK2/STAT3, ERK1/2, PKC-alpha, and Akt/GSK3
[8,21,29]. Additionally, leptin upregulates cdk2 and
cyclin D1 levels as well as inactivates of the cell cycle
inhibitor, pRb and consequently induces cell cycle pro-
gression [24].
Increased proliferation as well as deregulated apop-
tosis are important events in the process of carcino-
genesis. Ogunwobi et Beales [23] described stimula-
tion of proliferation and inhibition of apoptosis by lep-
tin of human colon cancer cells and this effect
involved JAK2, PI3-K and JNK activation. Despite
proliferative and anti-apoptotic activities of leptin in
different cells, there is increased number of evidences
presenting opposing results of leptin action on apopto-
sis. Leptin was reported to be responsible for the
induction of lipolysis and apoptosis of the adipose tis-
sue and precursor cells of the osteoblast lineage
[6,16,25]. The next possible proapoptotic mechanism
of leptin action involves increase production of reac-
tive oxygen species (ROS) [4, 34]. Thus data on asso-
ciation of leptin action with apoptosis are ambiguous
and to our knowledge there is lack of studies demon-
strating relationships between leptin system and pro-
teins associated with apoptosis in breast cancer.
In current study we aimed at assessment of eventu-
al relationships between leptin, leptin receptor and
selected protein regulators of apoptosis in breast can-
cer: Bcl-2, Bcl-xL, Bax and Bak.
Materials end methods
Patients and tissue specimens. Tissue samples were obtained
from 106 women who underwent partial or radical mastectomy
because of primary breast cancer in years 2000-2002. The age of
patients ranged from 30 to 80 years (mean 54.6 years). Tumor sam-
ples were collected immediately after tumor removal, fixed in 10%
buffered formaldehyde solution for 48 h and then embedded in
paraffin blocks at 56°C according to standard procedures. 5-µm
sections were cut from the specimens and stained with hema-
toxylin-eosin. The diagnosis was based on the WHO and pTN clas-
sification of breast tumors [31].
Immunohistochemistry. The immunohistochemical analysis of
leptin, leptin receptor, Bcl-2, Bcl-xL, Bak and Bax was investigat-
ed in representative tissue sections using antibodies: for leptin, rab-
bit polyclonal Ab (pAb) A-20 (Santa Cruz Biotechnology, Santa
Cruz, USA), dilution 1:100; for leptin receptor, rabbit pAb H-300
(Santa Cruz, USA), dilution 1:75; for Bcl-2, mouse monoclonal
antibody (Dako, Denmark), dilution 1:100; for Bcl-xL, goat pAb
(Santa Cruz, USA), dilution 1:300; for Bak and Bax, goat pAb
(Santa Cruz, USA), dilution 1:200. All primary Abs were diluted in
PBS with 1.5% normal blocking serum. Immunohistochemistry
was performed as described previously [17]. The studies were per-
formed with avidin-biotin-peroxidase complex (ABC Staining
System, SCBt, USA). Slides were counterstained with haema-
toxylin. In negative controls the primary antibody were omitted.
The expression of leptin, ObR, Bcl-2, Bcl-xL, Bak and Bax was
analyzed in 10 different tumor fields and the mean percentage of
tumor cells with positive staining was evaluated. The expression of
studied proteins in cancer samples was classified using a four-point
scale: 0, <10% positive cells; 1+, 10-50% positive cells with weak
staining; 2+, >50% positive cells with weak staining; 3+, >50%
positive cells with strong staining.
Statistical analysis. The significance of the associations between
studied proteins were determined using Spearman correlation
analysis. Probabilities of p<0.05 were assumed as statistically sig-
nificant.
Results
Immunohistochemical analysis of breast cancer sec-
tions revealed cytoplasmic localization and microgran-
ular staining for leptin, leptin receptor, Bcl-2, Bcl-xL,
Bak and Bax proteins. Immunostaining for leptin and
leptin receptor was observed in 92/106 (86.8%) and
44/106 (41.5%) of the tumors; for anti-apoptotic pro-
teins Bcl-2 and Bcl-xL in 79/106 (74.5%) and 77/106
(72.6%) of studied cases; for pro-apoptotic proteins
Bak and Bax in 71/106 (66.9%) and 61/106 (57.5%) of
the tumors, respectively.
Analysis of relationships between leptin and stud-
ied proteins showed statistically significant positive
correlation between leptin and anti-apoptotic protein
Bcl-xL (p<0.001, r=0.614) as well as between leptin
and pro-apoptotic Bak (p<0.001, r=0.518) and Bax
(p<0.001, r=0.511). On the other hand, leptin did not
correlate with anti-apoptotic Bcl-2 protein (p=0.789,
r=0.028).
We found statistically significant positive correla-
tion between leptin receptor and anti-apoptotic Bcl-xL
(p=0.011, r=0.210) as well as between leptin receptor
and pro-apoptotic Bax (p<0.001, r=0.313). Similarly
to leptin, we did not find significant association of lep-
tin receptor with anti-apoptotic Bcl-2 (p=0.738,
r=0.032). Additionally, correlation between leptin
receptor and pro-apoptotic Bak was not found
(p=0.378, r=0.086).
Discussion
Leptin system seems to play a dual role regarding
apoptosis as it can act either as a pro- or an anti-apop-
totic factor [3,4,6,16,23,25,34]. In the current study we
found statistically significant positive correlations
between leptin, its receptor and selected anti- and pro-
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apoptotic proteins in human breast cancer. It suggests
that leptin through auto- and paracrine mechanisms
might activate breast cancer to increased tumor cell
turnover and progression of the disease. 
Kim et al. [16] observed that leptin induces apop-
tosis of the precursor cells of the osteoblast lineage via
enhanced cytochrome c release into cytosol and the
activation of caspase-9 and 3. Opposing leptin action
reported Gordeladze et al. [10], who observed that lep-
tin stimulates proliferation and inhibits cells from
apoptosis. Qian et al. [25] found that intracerebroven-
tricular administration of leptin induced adipose tissue
apoptosis in addition to influencing lipid metabolism.
This pro-apoptotic leptin action was related on Perox-
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Fig 1. Immunohistochemical detection of leptin, leptin receptor, Bcl-2, Bcl-xL, Bak and Bax proteins. (a) The strong leptin staining is found
in primary tumor in above 50% of cancer cells. (b) Coarsely granular immunostaining fo leptin receptor. (c) Cytoplasmic immunoreactivity
to Bcl-2 in breast cancer. (d) Strong Bcl-xL immunostaining found in almost all cancer cells. (e) Moderate (assessed as 2+) Bak immunore-
activity in cancer cells. (f) Granular distribution of Bax in cytoplasm of breast cancer cells (original magnification ×200).
isome proliferator activated receptor γ (PPARγ) signal-
ing pathway. Also Gullicksen et al. [12] observed that
leptin treatment of rats led in different adipose tissues
to increase in Bcl-2 or Bax proteins. It caused signifi-
cantly reduction of adipose tissue cellularity by
increased DNA fragmentation and upregulation of pro-
apoptotic Bax protein. Proangiogenic leptin activity
was widely accepted. Artwohl et al. [3] observed that
leptin reduced apoptosis in human endothelial cells
and this action correlated with increased expression of
anti-apoptotic protein Bcl-2. On the other hand Cohen
et al. [6] reported that leptin enhances apoptosis in adi-
pose vascular endothelial cells. 
Hoda et al. [13] reported mitogenic and anti-apop-
totic leptin action for colon cancer cells, mediated via
MAPK and PI3-K pathways. Also Ogunwobi et Beales
[23] observed inhibition of apoptosis and stimulation
of proliferation by leptin in colon cancer cells. This
effect involved activation of JAK2, PI3-K, JNK,
STAT3 and AP-1 pathways. Stimulation by leptin of
multiple signaling pathways seems more complex
problem in the light of evidence that activation of JNK
could exert both anti- and pro-apoptotic action. Kim et
al. [15] reported JNK-mediated Bax activation with
stimulation of apoptosis. In our previous study [7] we
noted negative association between leptin expression
and proliferation marker Ki-67 in the group of lymph
node metastases derived from ERα-positive, but not
ERα-negative primary tumors. Also ObR negatively
correlated with Ki-67 in lymph node metastases of
breast cancer.
The next possible pro-apoptotic mechanism of lep-
tin action involves increase production of reactive
oxygen species (ROS). The increase of ROS was
observed under the influence of leptin in endothelial
cells and in polymorphonuclear neutrophils [4, 34].
ROS then mediate the formation of disulfide bridges
between cytosolic pro-apoptotic Bax monomers,
resulting in the formation of mitochondrial outer mem-
brane channels. Membrane permeabilization leads to
the release of apoptogenic proteins: cytochrome c,
apoptosis-inducing factor, Smac/Diablo, HtrA2/Omi
and endonuklease G. Cytochrome c initiates the prote-
olytic activation of caspases, which in turn cleave hun-
dreds of proteins to produce the morphological and
biochemical changes of apoptosis. The anti-apoptotic
proteins, such as Bcl-2 and Bcl-xL, exerts protective
role in apoptosis by preserving mitochondrial structure
and function [14]. A ratio of anti- to pro-apoptotic pro-
teins appears to determine the survival or death of cells
following an apoptotic stimulus.
Hypoxia, which is associated with solid tumors,
might stimulate, through hypoxia-inducible factor 1α
(HIF-1α), expression of multiple genes, especially
those encoding for glycolytic enzymes, growth factors,
their receptors and vasoactive peptides [28]. It was
found that hypoxia upregulates expression of leptin
which increased together with accumulation of HIF-1α
that enhance leptin expression via stimulation of
Hypoxia Responsive Element (HRE) located in the
promoter region of the leptin gene [2,11]. Previously,
in endometrial and colorectal cancers we noted a pos-
itive correlations between HIF-1α and leptin as well as
HIF-1α and ObR, which indicate that the expression of
the leptin system could be HIF-1α - dependent [18,
20]. There is also growing evidence about HIF-1α
involvement in the regulation of apoptosis [5,27]. In
our previous study, we observed relationships between
HIF-1α and Bax or Bcl-xL, which could suggest that
expression of these apoptotic proteins in cancer cells,
might be partially regulated by HIF-1α [33]. Observed
in the current study associations between leptin system
and apoptotic proteins could be also indirect and it's
not out of the question that expression of studied pro-
teins could depend on stimulatory influence of tumor
hypoxia and HIF-1α.
In conclusion, it seems that leptin by stimulation of
multiple intracellular signaling pathways could exert
two actions related to apoptosis, both increase and
inhibit this process. Consequently, leptin might
increase tumor cell turnover and breast cancer pro-
gression via promotion of both processes mitogenesis
and apoptosis, but functional relationships between
leptin system and apoptotic proteins should be studied.
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